Investment Thesis
American Healthcare REIT demonstrates exceptional net income growth (+298.9% YoY) and solid revenue growth (+7.9% YoY) supported by a fortress balance sheet with conservative 0.28x debt-to-equity leverage and strong 6.7x interest coverage. Positive free cash flow of $81.1M provides dividend capacity, though very low returns metrics (0.7% ROE, 0.4% ROA) and zero capital expenditure raise concerns about asset quality and capital allocation requiring investigation.
Strengths
- Exceptional net income growth of 298.9% YoY with solid operating margin of 19.3%
- Strong balance sheet with low leverage (0.28x D/E) and robust interest coverage (6.7x)
- Positive free cash flow of $81.1M with 12.5% FCF margin supporting distribution capacity
Risks
- Critically low ROE (0.7%) and ROA (0.4%) indicating poor returns on capital deployed
- Zero capital expenditure is anomalous for real estate company and may signal aging asset base or maintenance deferred
- Net income surge of 298.9% YoY likely contains non-recurring items; organic growth sustainability unclear
Key Metrics to Watch
- FFO (Funds From Operations) and AFFO trends - more meaningful than GAAP net income for REIT analysis
- Capital expenditure and maintenance reserve spending to assess asset reinvestment and property condition
- Healthcare property occupancy rates and lease renewal spreads indicating portfolio quality
Financial Metrics
Revenue
650.8M
Net Income
23.7M
EPS (Diluted)
$0.13
Free Cash Flow
81.1M
Total Assets
5.6B
Cash
119.4M
Profitability Ratios
Gross Margin
N/A
Operating Margin
19.3%
Net Margin
3.6%
ROE
0.7%
ROA
0.4%
FCF Margin
12.5%
Balance Sheet & Liquidity
Current Ratio
N/A
Quick Ratio
N/A
Debt/Equity
0.28x
Debt/Assets
37.1%
Interest Coverage
6.68x
Long-term Debt
980.0M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-09T09:23:46.648730 |
Data as of: 2026-03-31 |
Powered by Claude AI